273 related articles for article (PubMed ID: 21070604)
21. Novel insight into the agonistic mechanism of alefacept in vivo: differentially expressed genes may serve as biomarkers of response in psoriasis patients.
Haider AS; Lowes MA; Gardner H; Bandaru R; Darabi K; Chamian F; Kikuchi T; Gilleaudeau P; Whalen MS; Cardinale I; Novitskaya I; Krueger JG
J Immunol; 2007 Jun; 178(11):7442-9. PubMed ID: 17513795
[TBL] [Abstract][Full Text] [Related]
22. Corticosteroids and methotrexate as adjuvants to costimulation blockade in non-human primate renal transplantation.
Anderson DJ; Lo DJ; Leopardi F; Song M; Strobert EA; Jenkins JB; Larsen CP; Kirk AD
Clin Transplant; 2019 Jun; 33(6):e13568. PubMed ID: 31006146
[TBL] [Abstract][Full Text] [Related]
23. Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model.
Samy KP; Anderson DJ; Lo DJ; Mulvihill MS; Song M; Farris AB; Parker BS; MacDonald AL; Lu C; Springer TA; Kachlany SC; Reimann KA; How T; Leopardi FV; Franke KS; Williams KD; Collins BH; Kirk AD
Am J Transplant; 2017 May; 17(5):1193-1203. PubMed ID: 27888551
[TBL] [Abstract][Full Text] [Related]
24. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
[TBL] [Abstract][Full Text] [Related]
25. Effects of CD28 blockade on subsets of naïve T cells in cats.
Aronson LR; Drobatz KJ; Hunter CA; Mason N
Am J Vet Res; 2005 Mar; 66(3):483-92. PubMed ID: 15822594
[TBL] [Abstract][Full Text] [Related]
26. Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.
Stenger EO; Chiang KY; Haight A; Qayed M; Kean L; Horan J
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1845-52. PubMed ID: 26095669
[TBL] [Abstract][Full Text] [Related]
27. Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection.
Ville S; Poirier N; Branchereau J; Charpy V; Pengam S; Nerriere-Daguin V; Le Bas-Bernardet S; Coulon F; Mary C; Chenouard A; Hervouet J; Minault D; Nedellec S; Renaudin K; Vanhove B; Blancho G
J Am Soc Nephrol; 2016 Dec; 27(12):3577-3588. PubMed ID: 27160407
[TBL] [Abstract][Full Text] [Related]
28. Eomesodermin(lo) CTLA4(hi) Alloreactive CD8+ Memory T Cells Are Associated With Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates.
Ezzelarab MB; Lu L; Guo H; Zahorchak AF; Shufesky WF; Cooper DK; Morelli AE; Thomson AW
Transplantation; 2016 Jan; 100(1):91-102. PubMed ID: 26680373
[TBL] [Abstract][Full Text] [Related]
29. Alefacept, an immunomodulatory recombinant LFA-3/IgG1 fusion protein, induces CD16 signaling and CD2/CD16-dependent apoptosis of CD2(+) cells.
da Silva AJ; Brickelmaier M; Majeau GR; Li Z; Su L; Hsu YM; Hochman PS
J Immunol; 2002 May; 168(9):4462-71. PubMed ID: 11970990
[TBL] [Abstract][Full Text] [Related]
30. The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation.
Xu H; Perez SD; Cheeseman J; Mehta AK; Kirk AD
Am J Transplant; 2014 Feb; 14(2):319-32. PubMed ID: 24472192
[TBL] [Abstract][Full Text] [Related]
31. Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens.
Ashokkumar C; Ganguly B; Townsend R; White J; Levy S; Moritz M; Mazariegos G; Sun Q; Sindhi R
Sci Rep; 2015 Oct; 5():15218. PubMed ID: 26472085
[TBL] [Abstract][Full Text] [Related]
32. CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival.
D'Addio F; Ueno T; Clarkson M; Zhu B; Vergani A; Freeman GJ; Sayegh MH; Ansari MJ; Fiorina P; Habicht A
PLoS One; 2013; 8(4):e60391. PubMed ID: 23593209
[TBL] [Abstract][Full Text] [Related]
33. Identification and targeting of costimulation-resistant T cells in renal transplantation.
Farber DL
Am J Transplant; 2011 Jan; 11(1):8-9. PubMed ID: 21199342
[No Abstract] [Full Text] [Related]
34. The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation.
Reddy B; Gupta S; Chuzhin Y; Kalergis AM; Budhai L; Zhang M; Droguett G; Horwitz MS; Chowdhury JR; Nathenson SG; Davidson A
Transplantation; 2001 Mar; 71(6):801-11. PubMed ID: 11330546
[TBL] [Abstract][Full Text] [Related]
35. FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft.
Poirier N; Dilek N; Mary C; Ville S; Coulon F; Branchereau J; Tillou X; Charpy V; Pengam S; Nerriere-Daguin V; Hervouet J; Minault D; Le Bas-Bernardet S; Renaudin K; Vanhove B; Blancho G
Am J Transplant; 2015 Jan; 15(1):88-100. PubMed ID: 25488654
[TBL] [Abstract][Full Text] [Related]
36. Costimulatory blockade with mTor inhibition abrogates effector T-cell responses allowing regulatory T-cell survival in renal transplantation.
Bestard O; Cassis L; Cruzado JM; Torras J; Franquesa M; Gil-Vernet S; Lucia M; Grinyó JM
Transpl Int; 2011 May; 24(5):451-60. PubMed ID: 21294788
[TBL] [Abstract][Full Text] [Related]
37. High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept.
Krummey SM; Cheeseman JA; Conger JA; Jang PS; Mehta AK; Kirk AD; Larsen CP; Ford ML
Am J Transplant; 2014 Mar; 14(3):607-14. PubMed ID: 24730049
[TBL] [Abstract][Full Text] [Related]
38. Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway.
Ndejembi MP; Teijaro JR; Patke DS; Bingaman AW; Chandok MR; Azimzadeh A; Nadler SG; Farber DL
J Immunol; 2006 Dec; 177(11):7698-706. PubMed ID: 17114440
[TBL] [Abstract][Full Text] [Related]
39. Alloanergization of human T cells results in expansion of alloantigen-specific CD8(+) CD28(-) suppressor cells.
Barbon CM; Davies JK; Voskertchian A; Kelner RH; Brennan LL; Nadler LM; Guinan EC
Am J Transplant; 2014 Feb; 14(2):305-18. PubMed ID: 24410845
[TBL] [Abstract][Full Text] [Related]
40. ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys.
Song L; Ma A; Dun H; Hu Y; Fujii Y; Kinugasa F; Oshima S; Higashi Y; Daloze P; Chen H
Am J Transplant; 2017 Mar; 17(3):635-645. PubMed ID: 27598231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
